BNP Paribas Financial Markets’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Sell
16,203
-33,154
-67% -$370K ﹤0.01% 4310
2026
Q1
$587K Buy
49,357
+26,580
+117% +$272K ﹤0.01% 3493
2025
Q4
$227K Sell
22,777
-14,869
-39% -$142K ﹤0.01% 4006
2025
Q3
$337K Buy
37,646
+9,487
+34% +$87.9K ﹤0.01% 3761
2025
Q2
$266K Buy
28,159
+9,861
+54% +$87K ﹤0.01% 3670
2025
Q1
$198K Sell
18,298
-5,725
-24% -$57.6K ﹤0.01% 3704
2024
Q4
$229K Buy
+24,023
New +$243K ﹤0.01% 3788
2022
Q4
Sell
-58,169
Closed -$1.09M 4047
2022
Q3
$1.09M Buy
+58,169
New +$1.2M ﹤0.01% 2413

Other funds holding AHCO

BNP Paribas Financial Markets's AHCO Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its AdaptHealth (AHCO) stake by 67% in Q2 2026, selling an estimated $370K and leaving 16,203 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #4310.

BNP Paribas Financial Markets first reported a position in AHCO in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.09M in Q3 2022. 215 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • BNP Paribas Financial Markets held 16,203 shares of AdaptHealth worth $169K as of Q2 2026.
  • BNP Paribas Financial Markets sold 33,154 AdaptHealth shares in Q2 2026, an estimated $370K.
  • AdaptHealth made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4310 holding.
  • BNP Paribas Financial Markets first reported a position in AdaptHealth in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's AdaptHealth position peaked at $1.09M in Q3 2022.
  • 215 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.